Hello,



  • This field is for validation purposes and should be left unchanged.
EECO2 Privacy Policy

NEW CASE STUDY – MULTI-SITE GLOBAL ENERGY REDUCTION PROGRAMME

Our latest case study is based on a global pharmaceutical energy reduction programme. After a successful trial in Sydney, Australia, our client went on to introduce a corporate carbon and energy reduction programme globally. EECO2 worked with a further 10 of the client’s key sites, in the United States (6 sites), China (2 sites), Japan, UK and Australia.

Method: The EECO2 team conducted the on-site energy and water reduction assessment workshop events, working together with the site engineering teams and other stakeholders. The scope included a review of opportunities in HVAC systems serving all areas, utility generation & distribution (steam, chilled water, cooling water, compressed air systems) and water systems.

Results: EECO2 recommended that the client’s focus should be on rapidly implementing HVAC & BMS optimisation opportunities as these have high cost reduction, short paybacks and excellent emissions reductions. As an example, since the event took place, one site implemented optimisation of controls on several HVAC systems, which delivered $190k annual savings with a simple payback of 6 months. As well as the larger energy projects, the events identified 143 ‘Just Do Its’, which are low or no cost actions that site teams can action immediately. As well as the results below, the annual water savings identified was 47 Million Gallons, which is a 22% reduction! Projects have an average simple payback period of 3 years.

sign up to the eecO2 knowledge hub

By completing this form, you confirm that we may contact you via email, that you are over the age of 16 and that we can send you periodic emails, containing useful and interesting information including our email newsletter. Please see our privacy policy for more information and to see how you can manage your consent.

OUR CLIENTS

AbbVie

Aesica

ALKERMES

Allergan

Amgen

AstraZeneca

BAYER

Catalent

Eli Lilly

GlaxoSmithKline

Novartis

Pfizer

Pharmavite

Purogenix

Sanofi